media. Two different effects on plaque formation were found. With NWS antiserum, there was close relationship between reduction in plaque size and in plaque number [plaque inhibition (PI) pattern]. With RI/5 antiserum, plaque size reduction (PSR) occurred over a wide zone of serum dilutions without concomitant change in plaque number (PSR pattern). Several different preinoculation neutralization tests showed a strong reactivity of X-7 with NWS antisera and little if any reactivity with RI/5 antisera. We interpret the differing effects of NWS and RI/5 antisera on X-7 as indicative of the possible occurrence of different mechanisms of neutralization or of the possible participation of different surface antigens. The kinetics of PSR are consistent with the hypothesis that it results from the reaction of RI/5 antiserum with the RI/5-like neuraminidase of X-7. Studies with the antiserum-in-overlay technique of PSR and PI patterns comprise a sensitive method for quantitative antigenic analysis of plaque-forming influenza viruses.
When cell cultures inoculated with poliovirus are incubated under an overlay containing a homologous or a cross-reacting heterologous antiserum (19) , two end points may be observed: decrease in number of plaques and decrease in size of plaques (19) . The Wecker technique has been used extensively for the intratypic differentiation of polioviruses, with decreased plaque size (14, 18, 19) or decreased plaque number (12) as end points. Yet, there have been no reports describing the way in which the results obtained with these two end points vary with serial serum dilutions or with serial bleedings during immunization; thus, it is not known whether there are different patterns of relationship between reduction in plaque size and reduction in plaque number. Furthermore, it is not known whether there is a consistent relationship between the serum concentrations required to obtain decreased plaque size or decreased plaque number with the Wecker technique and those concentrations required to obtain decreased plaque numbers in the conventional (preinoculation) neutralization tests. The interest of this information extends beyond its applicability to the fine antigenic characterization of viruses. The demonstration of different patterns of plaque size reduction and plaque number reduction in the antiserumin-overlay test and in conventional neutralization tests could point to different mechanisms of virus neutralization, or to basic differences in the antigenic structure of viruses.
During studies of recombinants of Ao/NWS and A2/RI/5+ influenza viruses (4, 6) , a recombinant with dual antigenic reactivity was isolated (E. D. Kilboume et al., Perspectives Virol., in press). This recombinant, X-7, was initially characterized in hemagglutination-inhibition tests as NWS-like, but with "minor" RI/5+-like reactivity in strain-specific complement-fixation tests and in mouse infection. In addition, incorporation of NWS or RI/5+ antisera into agar JAHIEL AND KILBOURNE overlays in a stable cell line plaquing system (16) resulted in complete plaque inhibition (PI) of X-7 with X-7 or NWS antisera. However, a different effect, plaque size reduction (PSR), resulted with antiserum to the RI/5+ parent. TIhese differing patterns of antigenic reactivity and their implications are the subject of the present report.
MATERIALS AND METHODS
Cells. Clone 1-5C-4, a human heteroploid cell derived from a variant line of the Chang conjunctival cell (21) , was used. The methods for growth and maintenance of this clone have been described (16) .
Viruses. X-1L and X-7 were the products of recombination between NWS-MK-p (an Ao strain) and RI/5+ (an A2 strain). The parent strains, as well as the related strains NWS-34, RI/5-,RI/5+ (MK), and RI/5-(MK), and the influenza B/Lee strain have been described (5, 16) . The experiment in which these recombinants were obtained is described elsewhere (E. D. Kilbourne et al., in press ). Significant features of that experiment, as well as the further passage and cloning history of the virus, are summarized in Fig. 1 . Recombinant X-7 (Fl) was isolated after recombination of X-7 and RI/5+ (MK).
Plaque assay techniques. The preparation of 60-mm Falcon dish cultures and the procedures for virus inoculation and adsorption have been already described (16) . The agar overlay was Sugiura and Kilbourne's serumless medium 1 (16) . Incubation was at 35 C in a humidified atmosphere of 3% CO2, for 4 days, unless stated otherwise. The overlay was removed by gently separating it from the upturned plate with forceps. The plates were washed once with phosphate-buffered saline, and the cultures were fixed and stained in situ by immersion for about 1 min in 0.1% crystal violet in 20% ethyl alcohol in water, rinsing in tap water, and drying. Alternatively, monolayers were fixed in Bouin's solution, stained with Mayer's hematoxylin for 10 to 30 min, rinsed with 5% NaHCO3 and distilled water, and then dried. very sharp fall in cell population density at the edge of the plaque. Because the plaques were very nearly circular, their size could be accurately measured by superimposing on the plaque tracing a transparent medium on which concentric circles with 2.1-cm radial increments were drawn. The plaque's radius and surface were fitted to those of the nearest circle.
PLAQUE SIZE REDUCTION unidirectional error. Unless stated otherwise, the size of all the plaques in the plate was measured.
Antisera. Antisera were prepared in rabbits by initial intravenous injection of 103-.6 to 105-°hemag-glutination (HA) units of allantoic fluid virus concentrated by ultracentrifugation, followed by intraperitoneal injections of 10' 7 to 105.6 HA units at 7 to 10 days and finally 105-3 to 1062 HA units at 15 to 20 days and at subsequent injections. An RI/5-antiserum produced by a different immunization procedure was obtained from W. G. Laver and R. Webster of the Australian National University in Canberra. To produce this serum (LW5), allantoic passage RI/5-virus was adsorbed to red blood cells and eluted and purified further by sucrose gradient centrifugation; two samples of the purified preparation, containing 3,000 HA units each, were injected intravenously, at 40-day intervals, and the rabbit's blood was collected 7 days after the last injection. All sera were heated for 30 min at 56 C prior to use, but were not otherwise treated.
Virus neutralization tests in ovo. Equal volumes of serial serum dilutions and of virus diluted to yield 102 EID5 per 0.1 ml were mixed and allowed to react at 4 C for 1 hr, and 0.1 ml of the mixture was inoculated into the allantoic cavity of 12-day-old chick embryos. After 40 hr of incubation at 37 C, the allantoic fluids were collected, diluted 1:4 with phosphate-buffered saline, and tested for hemagglutination with human 0 red blood cells as described previously (21) .
"Postinoculation neutralization" (antiserum-inoverlay test or Wecker technique). Adsorption, addition of overlay, and inoculation of 20 to 150, or more, PFU (plaque-forming units) of virus were performed as in the usual plaque assay (16) , except that the overlay contained dilutions of antiserum. The inoculum was not removed routinely, because comparative experiments had shown that this had little effect in this system on the number and size of plaques. The end points were the number and size of plaques after 4 days of incubation unless stated otherwise.
The abbreviation "PSR" is used to describe a plate in which the size of plaques is decreased as compared with controls. The abbreviation "Pl" is used in this paper to describe a plate in which the number of plaques is decreased as compared with the control, or a plate in which there are no plaques. The abbreviations "PSR titer" (plaque size reduction titer) and "PI titer" (plaque inhibition titer) are used to refer to the point at which a 50% decrease in median plaque radius and number of plaques per plate, respectively, occurred. The abbreviation "PSR pattern" is used to refer to a titration in which plaque size reduction without plaque number reduction was present over a wide range of dilutions; the abbreviation "PI pattern" is used to refer to a titration in which plaque size reduction (PSR) occurred only in close association with reduction in plaque numbers (PI). The above abbreviations are used in the text only when it appears that their use is unambiguous. The above terms and their abbreviations are used only in reference to the antiserum-in-overly neutralization test.
Hemagglutination and hemadsorption tests. The hemagglutination (HA) and hemagglutination-inhibition (HI) titration methods have already been described (21) . Microscopic hemadsorption (MHA) was performed by washing the plates twice with about 5 ml of phosphate-buffered saline after removing the agar overlay, and then adding 2 ml of a 0.1% (v/v) suspension of human group 0 red blood cells. The cells were allowed to react for 10 to 15 min at room temperature before they were washed twice gently with phosphate-buffered saline and fixed in Bouin's solution. Hemadsorption, which could sometimes be seen grossly, was determined microscopically, after fixation or after further staining in hematoxylin. Hemadsorption allowed the detection of plaques of radius smaller than 0.1 mm. A hemadsorption plaque is illustrated in Fig. 2 .
RESULTS
Initial observation. Cultures inoculated with 60 PFU of X-7 were incubated under overlays containing NWS or RI/S antiserum or normal rabbit serum in a final dilution of 1:400. After 4 days of incubation, there were no plaques in the plates with the NWS antiserum, whereas the plates with the RI/5+ antiserum showed the same number of plaques as the control, but with markedly reduced plaque size. This result, which resembled the observations of Wecker (19) The RI/5+ antisera had no effect on plaque number at any dilution used, beyond that observed with normal serum. They did, however, reduce plaque size considerably more than did normal serum; the reduction was evident up to dilutions of 1:4,000. The NWS antisera produced an initial zone of complete plaque inhibition, followed by a narrow zone in which both size and number of plaques were reduced. Additional experiments showed that X-7 antiserum had the same pattern of effects on X-7 as did NWS antiserum and showed that NWS antiserum had the same pattern of effects on NWS virus as it did on X-7 virus. Experiments in which microscopic hemadsorption was used did not result in a change in the PI titer of NWS antiserum with NWS and X-7 viruses. Therefore, the zone of complete plaque inhibition in these systems is not a zone in which plaque size is reduced to a point where the plaques are too small to be detected by ordinary microscopic examination. Thus, occurrence of plaque size reduction without concomitant change in plaque number at any serum dilution (PSR pattern) in the X-7 virus-RI/5 antiserum system is a pattern of reactivity distinct from the change in plaque size and number (PI pattern), observed with X-7 virus and either X-7 (homotypic) or NWS antisera.
A Kinetics ofplaque growth of X-7 under overlays containing RI/S antisera. PSR of X-7 after 4 days of incubation under RI/5 antiserum could have been due either to a continuously lower plaque growth rate during that period or to an initial inhibition of plaque development followed by a resumption of plaque growth in a manner analogous to the "breakthrough" phenomenon (20) . To distinguish between these two possibilities, cultures inoculated with 50 to 100 PFU of X-7 were incubated under an overlay containing RI/5+ antiserum or control serum in a final dilution of 1: 500 and were fixed at daily intervals. The control serum was RI/5+ antiserum adsorbed with RI/5+ virus. The results are shown in Fig. 4 and 5. There was little difference between RI/5+ antiserum and control serum in the variation in plaque number with time (Fig. 4) . The low number of plaques in both plates on the 2nd day was associated with plaque sizes bordering the lower limit of discernibility. This experiment was performed without microscopic hemadsorption so that plaques with a radius smaller than 0.1 mm could not be differentiated from nonspecific holes in the monolayers. The median plaque radius with control serum and RI/5+ antiserum varied with time according to a curve which was close to a straight line, particularly when corrected medians were used ( Fig. 4b and c) Fig. 1 . The plaque size of X-7 with serumless overlays and the occurrence of PSR with RI/5+ antisera were stable features during these transfers (Table 1) . Virus recovered from X-7 plaques of reduced size in plates with RI/5+ antiserum overlay did not differ qualitatively or quantitatively from X-7 either in its plaque size with serumless overlays or in its susceptibility to plaque size reduction with RI/5+ antiserum overlay, as is illustrated by the following experiment (Fig. 6 ). Cultures inoculated with X-7 were incubated for 6 days under overlays either containing no serum or containing RI/5+ antiserum. This prolonged incubation was chosen to obtain a better resolution of small differences in plaque size. One plaque near the median of the frequency distribution of plaque size (plaque a) was picked from a plate with serumless overlay, and two plaques (b and c), representative of the two extremes of plaque size, were pieked from RI/5 antiserum plates. Virus from each of these three plaques was inoculated into two plates, one of which was incubated without serum and the other with RI/5+ antiserum in the overlay. The frequency distribution of plaque size in these plates is illustrated in Fig. 6 . All three plates with the serumless overlay showed the same plaque size frequency distribution, and all three plates with RI/5 antiserum overlay showed PSR of the same extent. including those sensitive and resistant to inhibitors, is shown by antiserum-in-overlay tests performed with X-7 and several RI/5 antisera ( Table  2 ). These data show that the ability to cause PSR of X-7 is not an occasional serological response of individual rabbits, but a regular response of rabbits to RI/5 immunization. All RI/5 antisera exhibited a wide zone of plaque size reduction without change in plaque number, extending over a 16-fold or greater range of dilutions; the occurrence of this zone appeared to be independent of the PSR titer of the serum, since it was found with sera ranging in titer from 1:1,000 to 1: 64,000. Thus, a marked dissociation of the PI and PSR end points with X-7 appears to be a regular feature of the serological response of rabbits to RI/5 immunization. Indeed, it is questionable whether any PI of X-7 has been demonstrated with RI/5 antisera; the only possible instance of a plaque inhibitory titer beyond that of normal serum was with the high titer LW5 serum (Table 2 ). Microscopic examination revealed plaque size reduction without decreased plaque numbers at a dilution of 4,000, and there were numerous microscopic plaques at dilutions of 2,000 and 500. However, the poor quality of the monolayers at these dilutions in this experiment precluded definitive interpretation. a This was the preimmunization serum of the same rabbit whose immune serum was used in that experiment, except in the case of rabbit LW5 when the preimmunization serum of another rabbit (LW9), also received from Australia, was used, and in the case of the experiment with X-7 (Fl) when the control serum was the R232 immune serum after adsorption with X-7.
b Reciprocal of highest dilution showing 50% reduction in median plaque radius (PSR) and plaque number (PI) .
cate that the dissociation of plaque size reduction from reduction in plaque number (PSR pattern) is a property exhibited by RI/5 antisera only with certain viruses like X-7, and that RI/5 antisera are capable of plaque size reduction in close association with plaque number reduction (PI pattern). They also show that X-7 can remove from RI/5 antisera an antibody capable of causing at least operational PI with another virus, X-7(F1). These data are consistent with the hypothesis that the same antibody is responsible for X-7 plaque size reduction and for X-7(F1) plaque inhibition. They do not exclude other interpretations.
P1 with X-7 as a regular serological response of rabbits to NWS immunization. The contrasting pattern of close relationship of plaque size reduction with plaque number reduction was exhibited by X-7 with several different NWS antisera ( Table  2 ). The use of microscopic hemadsorption usually revealed a few additional microscopic plaques, but considering those did not change the PI titers. NWS antisera PI titers with X-7 and with NWS were very close ( Table 2) .
Relation of time after immunization to the ability of a serum to produce PSR or PI. Other experiments were performed to find whether the ability of a serum to produce PSR or PI with X-7 virus was influenced by the time at which the serum is obtained after immunization. Rabbits were bled 4, 7, and 10 days after a single injection of RI/5+, RI/5-, and NWS viruses. The rabbits injected with NWS were also bled on the 2nd day. These sera, at a final dilution of 1:250, were incorporated in the overlay of plates inoculated with X-7. The only response observed with the RI/5 antisera was PSR; it was demonstrable in three of four 4th-day sera and in all four 7th-and 10th-day sera; the degree of plaque size reduction increased with time after injection. Plates overlaid with the second day NWS antisera showed decreased plaque size and plaque number when compared with preimmunization serum. Titration of one of the 2nd-day NWS antisera yielded PI and PSR end points of 125 Table 3 . The NWS antisera neutralized X-7 and NWS viruses in cell culture and in ovo at high dilutions; the titers with X-7 viruses were very close to those obtained with NWS virus; the serum dilution titers obtained with these viruses in preinoculation neutralization tests were 2-to 32-fold lower than the titers of the same sera with the same viruses in the antiserum-inoverlay test (Tables 2 and 3 ). The RI/5+ and RI/5-antisera neutralized RI/5-in cell cultures and in ovo at high dilutions, with titers comparable to those of the NWS antisera with their homologous viruses. However, RI/5 antisera showed neutralizing activity against X-7 only at very low dilutions -the titers varied between less than 4 and 16; i.e., they were 100-fold to more than 1,000-fold lower than their titers with the RI/5 homotypic virus, and more than 1,000-fold lower than the PSR titers of the same sera with X-7 (Tables 2 and 3 ). There were no prozones nor any evidence of enhancement of infectivity by antisera as described in other systems (3). These results point to another difference in the behavior of X-7 with antisera to its two parental viruses and also show a remarkable lack of parallelism between the results of PSR and of preinoculation neutralization tests in the X-7-RI/S antiserum system.
Preinoculation neutralization tests with concentrated virus. In another type of preinoculation neutralization test (Fig. 7) , samples of virus containing 107 PFU per 0.1 ml were mixed with equal volumes of 1:32 dilutions of serum and allowed to react at 4 C. At serial intervals, up to 3 hr, portions were removed, appropriately diluted for plaque assay, and inoculated as described above for the serum-dilution preinoculation neutralization test. With the NWS antiserum, the neutralization kinetics exhibited a biphasic curve, similar to the one described by Lafferty (8) . The RI/5 antisera showed only a slow phase, ifany, with a two-to three-fold reduction at most in PFU over a 3-hr period. Normal serum had no detectable effect under these conditions.
Modified disc method. To approximate more closely the environmental conditions under which PSR is demonstrated (temperature, agar and other components of the overlay, etc.), a modifi- Six plastic cylinders (0.6 by 1 cm) were set on the overlay after it solidified, and 2 more ml of the same overlay was added outside the cylinders and allowed to solidify; one cylinder received 0.2 ml of medium 199, and the other five received serial dilutions of X-7 ( Table 4 ). The plates were incubated for 5 days; the location of the monolayer underlying the cylinders was marked, and, after the overlay was removed and plates were stained, the number and size of the areas of cell necrosis were recorded. The virus added to the cylinders had to diffuse through the serum-containing overlay before reaching the cells; after the first cycle, the progeny were again, presumably, in contact with the serum in the overlay. This test thus has features of both "preinoculation" and "postinoculation" neutralization tests. A positive neutralization (i.e., no areas of necro- sis) would not distinguish between neutralization that occurred before and after the first cycle, but a negative neutralization (i.e., no difference in occurrence of necrosis with control) would indicate at least failure to neutralize before the first cycle. The results are shown in Table 4 . Three logs more virus were required in the presence of NWS antiserum than in the presence of normal serum for the induction of necrosis. There was less than 1 log unit difference between RI/5 antiserum and normal serum.
Thus, there is a discrepancy between the high reactivity of X-7 with RI/5 antiserum in the overlay with plaque size reduction as end point and its low reactivity, if any, with plaque inhibition as end point, in three types of preinoculation neutralization tests.
DISCUSSION
The reduction of plaque size of X-7 virus by RI/5 antiserum in the overlay has threefold interest. It is the end point of a simple test with which certain antigenic components of influenza recombinant viruses can be detected rapidly and easily; secondly, its study reveals a pattern of effects of virus-antibody reaction on plaque number and size which differs from that exhibited by other influenza virus-antibody systems; and lastly, it represents, as a result of a virus-antibody reaction, a modification of viral plaque pathogenesis that can be analyzed in terms of the antigenic constituents of influenza viruses and of their function in the virus-cell interaction.
The simplicity of the antiserum-in-overlay technique and its ability through PSR The use of a recombinant virus in these experiments has shown that more than one pattern of plaque size reduction and plaque number reduction can occur as the result of virus-antibody reaction. The parental NWS and RI/5 rabbit antisera have two different patterns of reactivity with the NWS-RI/5 hybrid X-7 virus when incorporated into agar overlay in cell culture, namely, plaque size reduction closely associated with reduction in plaque number (PI pattern) and plaque size reduction without any demonstrable change in plaque numbers over a wide range of serum dilutions (PSR pattern). A small increment in the concentration of NWS antibody causes a shift from no effect on X-7 plaques to complete inhibition; the failure to detect any plaques at these dilutions, even with microscopic hemadsorption, indicates that NWS antiserum prevents the development of X-7 plaques by preventing the occurrence of the second cycle or of the early part of the multicycic process leading to plaque formation. The simplest hypothesis to account for this is that virus liberated by the initially infected cell is irreversibly neutralized and that this process continues for the duration of the period of observation, or until the infected cell stops releasing virus. Interpretation of the effect of RI/5 antiserum must consider the kinetics of X-7 plaque growth in the presence of RI/5 antiserum; i.e., the variation in plaque radius with time remains linear but with a lower slope than with the control serum. These results indicate that RI/5 antibody acts on X-7 throughout the period of observation, and its effect at any given time is to reduce plaque growth to a constant fraction of the control plaque growth. The results of the antiserum-in-overlay titration indicate that X-7 plaque size growth rate is sensitive to the amount of RI/5 antibody.
Hypothetical mechanisms for plaque size reduction of X-7 by RI/5 antiserum must take into account the results of other immunological reactions besides those demonstrated with the antiserum-in-overlay systems. Several tests have shown no or, at most, equivocal "preinoculation" neutralization of X-7 virus by RI/5 antiserum. Electrophoretic analysis of the proteins of X-7 has shown that the only demonstrable component shared by X-7 and RI/5 viruses is neuraminidase (W. G. Laver and E. D. Kilbourne, Virology, in press). Present evidence suggests the antigenic identity of X-7 and RI/5 neuraminidases (Laver and Kilbourne, in press).
These data are consistent with the following hypothesis. RI/5 antibody cannot neutralize X-7 virus before the first cycle of viral multiplication. Its reaction with X-7 neuraminidase on or at the surface of the infected cells decreases the yield, at each cycle, by a constant fraction or increases the mean latent period. This hypothesis fits all experimental facts, as well as the concept of virus-specified antigenic changes at the surface of influenza infected cells (2) and recent evidence suggesting that neuraminidase plays a role in influenza virus release (13) .
Another hypothesis, based on the idea that the significant feature of the RI/5 component of X-7 viral protein is that it is a "minor" antigenic component, has been presented elsewhere (6) . This hypothesis interprets plaque size reduction in terms of Lafferty's model of influenza virus neutralization (9) . It postulates that X-7 has a majority of closely spaced NWS determinants, allowing bridging by NWS antibody between sites on the same virus particle, and has few accessible RI/5 determinants, allowing bridging by RI/5 antibody only between sites on two different virus particles. The latter reaction would cause agglutination of X-7 particles and contribute to plaque size reduction by decreasing the number of infectious units and by slowing diffusion. The results presented here do not rule out this hypothesis but point to the need for additional assumptions to reconcile it with the discrepancy between the preinoculation and antiserum-in-overlay tests.
The results obtained with the RI/5-X-7 backcross, X-7(Fl), show that, irrespective of whether or not the reaction of X-7(Fl) with RI/5 antiserum is interpreted as PI or as an extreme PSR pattern, it is clear that the X-7(F1) (backcross) virus has more A2 reactivity than X-7. This variation in reactivity of minor component is reminiscent of the results found with comple- An ancillary aspect of this work is the demonstration of another system in which plaque growth kinetics appear to be linear with respect to plaque radius. There are now several such systems, including bacteriophage (7), vaccinia (10), foot-and-mouth disease (15) and certain echo 6 strains (1). The X-7 virus-RI/5 antiserum system provides a new method for decreasing the slope of the plaque radius growth curve at will through change of the antiserum concentration.
